Palantir Technologies Today
Palantir Technologies
As of 04:00 PM ET
- 52 week range
- $40.36
▼
$190.00
- P/E ratio
- 598.75
- Price target
- $141.28
Palantir Technologies Inc NASDAQ:PLTR And OneMed Net Company. Nasdaq:ONMD He owns I agreed to the partnership Which will leverage Palantir’s Artificial Intelligence Platform (AIP) to enhance its healthcare AI capabilities and data analytics. Specifically, Palantir will provide the infrastructure for OneMedNet’s iRWD network, a near real-time AI-powered provider network.
This partnership will help OneMedNet accelerate the use of real-world imaging data in clinical research. OneMedNet provides access to more than five billion administrative claims and 131 million clinical examinations across more than 1,750 provider sites, including oncology, cardiology and rare diseases.
The partnership strengthens Palantir’s role in healthcare AI
This multi-year agreement deepens Palantir’s footprint in the healthcare and life sciences sector, following its previous collaborations with the US Food and Drug Administration, National Institutes of Health and leading pharmaceutical companies. It also enhances Palantir’s credibility in the regulated health data environment, which requires secure and compliant handling of sensitive information, such as HIPAA.
It also highlights how Palantir is positioning itself at the center of an AI-driven transformation for biomedical data management, an area seeing rapid investment and regulatory support.
The commercial growth shows Palantir’s expanding reach
It wasn’t that long ago when the primary criticism of Palantir was that the company was too dependent on US government revenues. However, in the most recent quarter, the company posted year-over-year U.S. merchant revenue growth of 93%, and its number of customers increased by 64%.
Palantir says it is on track to achieve U.S. commercial revenue guidance of more than $1.302 billion, representing a growth rate of at least 85%. About 44% of the company’s total revenue comes from the business side. And the contract with OneMedNet isn’t the only business win Palantir has announced since it last reported earnings.
PLTR stock continues to attract institutional interest
Over the past year, analysts have consistently raised their price targets for PLTR stock. At one point, the agreed upon price was in the $60s, then in the $80s. Today, a Palantir analyst forecast on MarketBeat gives the stock a consensus price target of $141.28. This represents a 20% decline from its closing price on October 14. But at one time, this gap was much wider.
This should remind investors that monitoring what investors do is more important than what they say. It’s fair to say that Palantir is trading at a premium. However, contracts like the one it signed with OneMedNet make clear why the stock deserves the premium it gets.
Bullish options activity signals confidence ahead of earnings
Palantir Technologies stock forecast today
$141.28
-21.35% negativesHe catches
Based on 22 analyst ratings
| Current price | $179.62 |
|---|---|
| High expectations | $215.00 |
| Average expectations | $141.28 |
| Low expectations | $45.00 |
Palantir Technologies stock forecast details
PLTR stock is up more than 137% in 2025 and 20% in the past three months, making it a standout in the technology sector. However, this growth slowed to about 4.8% in the past month. The simple reason is that momentum has run out after a strong rally, and the stock is consolidating in a range between about $173 and $187.
Investors have seen this before, and it happens more often around earnings. Palantir reported earnings in about three weeks on November 3. A strong report will be the only incentive investors need to jump-start the stock’s momentum.
Analysts were relatively calm. However, options traders are placing bullish bets. Palantir’s options series for November 7 (the Friday following the company’s earnings report) shows significantly higher call volume than put volume, especially at higher strike prices between $180 and $200, where open interest and implied volatility rise.
The $200 price results in over 2,600 open contracts and high interest (+633), indicating that traders are preparing for continued bullish momentum.
However, traders should be advised that short interest in PLTR shares has risen by about 10% in the past month. If a company’s earnings fall short of expectations or even meet expectations, this could incentivize sellers to push the stock lower.
Before you consider Palantir Technologies, you’ll want to hear this.
MarketBeat tracks the highest-rated and best-performing research analysts on Wall Street and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches up… and Palantir Technologies was not on the list.
While Palantir Technologies currently has a Hold rating among analysts, top-rated analysts believe these 5 stocks are better buys.
View the five stocks here
Looking for the next FAANG stock before everyone hears about it? Enter your email address to see which stocks MarketBeat analysts think could become the next trillion-dollar tech company.
